Seegene, Inc. (KOSDAQ:096530)
23,900
+550 (2.36%)
Apr 10, 2026, 3:30 PM KST
Seegene Revenue
In the year 2025, Seegene had annual revenue of 474.23B KRW with 14.48% growth. Seegene had revenue of 130.63B in the quarter ending December 31, 2025, with 13.26% growth.
Revenue
474.23B
Revenue Growth
+14.48%
P/S Ratio
2.27
Revenue / Employee
2.20B
Employees
216
Market Cap
1.08T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 474.23B | 59.98B | 14.48% |
| Dec 31, 2024 | 414.25B | 46.88B | 12.76% |
| Dec 31, 2023 | 367.38B | -486.19B | -56.96% |
| Dec 31, 2022 | 853.56B | -517.27B | -37.73% |
| Dec 31, 2021 | 1.37T | 245.62B | 21.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| i-SENS | 315.44B |
| InBody Co.,Ltd | 233.95B |
| WON TECH | 156.84B |
| Osang Healthcare Co.,Ltd | 128.63B |
| DRTECH | 116.30B |
| Bio Plus | 90.90B |
| L&C BIO Co.,LTD | 85.48B |
| Curexo | 74.53B |